AbbVie Inc. logo

ABBV

AbbVie Inc.

$250.94
-2.51%
AbbVie Inc logo

AbbVie Inc

AbbVie Inc is a Biotechnology company listed on NEW YORK STOCK EXCHANGE, INC..

Industry
Biotechnology
Exchange
NEW YORK STOCK EXCHANGE, INC.
Market Cap
$443.4B
P/E Ratio
122.0
Cash on Hand
$5.3B(positive)
Shares Outstanding
1.77B shares
Visit website →

About

AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.

via Wikipedia →

Earnings (EPS)

QuarterEPS EstimateEPS Actual
Q2 2026$3.68$3.65
Q1 2026$2.65$2.65
Q4 2025$2.71$2.71
Q3 2025$1.81$1.86

Financial Highlights

The basics, explained simply — no finance degree required.

52-Week Range
$187.62 – $267.47

The lowest and highest price this stock has traded at over the past year.

Dividend Yield
2.69%

How much this stock pays you back each year, just for holding it — as a % of the share price.

Profit Margin
5.8%

How much of every $1 in sales turns into actual profit. Higher generally means a healthier business.

Revenue Growth
+9.5%

How much the company's sales grew compared to a year ago.

Volatility (Beta)
0.27

How much this stock tends to swing compared to the overall market. Above 1 means it typically moves more than the market (higher risk, higher potential reward); below 1 means it's historically calmer.

Insider Activity

Recent buys and sells by company executives and directors — publicly disclosed, as required by law.

RAPP EDWARD J
Jun 30, 2026 • $251.64/share
Bought 134
Quaggin Susan E
Jun 30, 2026 • $251.64/share
Bought 62
AUSTIN ROXANNE S
May 8, 2026
Bought 1,118
RAPP EDWARD J
May 8, 2026
Bought 1,118
FALK THOMAS J
May 8, 2026
Bought 1,118
WADDELL FREDERICK H
May 8, 2026
Bought 1,118

Recent News